January 29, 2020 Reverse mergers give and they take away Investors in Conatus, and especially those in Newlink, should question how valuations of the groups' reversing acquirers have been calculated.
April 13, 2018 Snippet roundup: Icer gives migraine price advice and Bellicum restarts stem cell trial
August 22, 2017 The sector’s most valuable unpartnered assets – up for grabs or on the shelf? Pharma companies have passed on in-licensing drugs such as Kite Pharma’s CAR-T therapy and Incyte’s IDO inhibitor. Do they know something?